ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 177 filers reported holding ARGENX SE in Q4 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $80 | -99.4% | 218 | +407.0% | 0.00% | – |
Q3 2022 | $14,000 | -63.2% | 43 | -58.3% | 0.00% | – |
Q2 2022 | $38,000 | +192.3% | 103 | +134.1% | 0.00% | – |
Q1 2022 | $13,000 | +62.5% | 44 | +76.0% | 0.00% | – |
Q4 2021 | $8,000 | +60.0% | 25 | +47.1% | 0.00% | – |
Q3 2021 | $5,000 | 0.0% | 17 | 0.0% | 0.00% | – |
Q2 2021 | $5,000 | +25.0% | 17 | -10.5% | 0.00% | – |
Q1 2021 | $4,000 | -97.5% | 19 | -96.5% | 0.00% | -100.0% |
Q4 2020 | $161,000 | -3.6% | 550 | -13.9% | 0.00% | -50.0% |
Q3 2020 | $167,000 | +36.9% | 639 | +18.3% | 0.00% | +100.0% |
Q2 2020 | $122,000 | +6000.0% | 540 | +3275.0% | 0.00% | – |
Q1 2020 | $2,000 | – | 16 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Darwin Global Management, Ltd. | 297,701 | $112,778,070 | 70.21% |
Artia Global Partners LP | 85,204 | $32,277,831 | 12.30% |
Avoro Capital Advisors LLC | 1,265,555 | $479,430,201 | 7.16% |
DCF Advisers, LLC | 25,000 | $9,470,750 | 6.40% |
Eagle Health Investments LP | 60,300 | $22,843,449 | 5.27% |
Avidity Partners Management LP | 625,000 | $236,768,750 | 5.13% |
Bellevue Group AG | 911,100 | $345,152,013 | 4.58% |
Fairmount Funds Management LLC | 73,526 | $27,853,855 | 4.42% |
Paradigm Biocapital Advisors LP | 89,556 | $33,926,499 | 3.98% |
RTW INVESTMENTS, LP | 482,195 | $182,669,932 | 3.73% |